Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangxi Lingfeng Pharmaceutical is a prominent Chinese pharmaceutical manufacturer and a core subsidiary of the Golden Throat Group. The company specializes in the research, development, and production of Traditional Chinese Medicine (TCM) and modern health products, most notably the flagship Golden Throat Lozenges (Jin Sang Zi Hou Pian). Based in Wuzhou, Guangxi, Lingfeng operates large-scale GMP-certified facilities producing a wide range of dosage forms including tablets, capsules, and oral liquids. Its portfolio addresses diverse therapeutic areas such as respiratory health, cardiovascular conditions, and digestive disorders. The company is a key player in the Chinese OTC market and maintains a significant export business for its herbal health products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangxi Lingfeng Pharmaceutical.